IFF Says Probiotics Cool-Off Is ‘Understandable,’ Fine Fragrance Growth A Welcome Surprise
Executive Summary
Destocking of probiotics and vitamins as a result of softening consumer demand post-pandemic dragged on International Flavors & Fragrance’s Health & Biosciences business in the third quarter, while mid-teens growth in fine fragrance and fragrance ingredients drove 9% comparable sales growth for the New York firm’s Scent division, reported on 7 November.
You may also be interested in...
IFF Will Be Slimmer, Simplified And Better Aligned With End-Markets – CEO Clyburn
New York-based International Flavors and Fragrances is shooting for 4%-6% top-line growth in currency-neutral sales over the 2024-2026 period, versus 2%-3% today, through a long-term strategic transformation that will streamline operations while repositioning to meet customer needs better from a category perspective.
Coty ‘Advantaged’ In FY 2023 With Consumer Biz Momentum, Unflagging Luxury Fragrance Demand
Coty leadership says it has not seen any slowdown in fragrance “premiumization” trends, which bodes well for its booming Prestige business. Strong momentum in Consumer Beauty and a robust innovation pipeline across both divisions have the firm targeting 6%-8% like-for-like growth in fiscal 2023.
IFF’s ‘Differentiating’ R&D This Year Includes Probiotics, Biodegradable Fragrance; Q1 Sales Increase 13%
New York firm International Flavors & Fragrances Inc. aims to stand out in 2022 with an R&D pipeline that includes probiotics, plant-based protein and biodegradable fragrances, says CEO Frank Clyburn, speaking in his first quarterly earnings presentation since taking the helm in February.